Jay M. Moyes, Director at PUMA BIOTECHNOLOGY, INC. (PBYI), sold 22,000 shares at $3.34 ($73K) on 2024-06-13, disclosed to the SEC on 2024-06-17.
Scheduled sale ($73k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| SINT | BUY | 2025-08-27 | $11K | — | Filing → |
| PBYI | SELL | 2025-06-17 | $75K | — | Filing → |
| PBYI | SELL | 2023-06-15 | $76K | — | Filing → |